Jeffery Schloss, NHGRI, to Keynote Speak at GTCbio’s 6th Next Generation Sequencing

Boston, MA, April 16, 2016 --(PR.com)-- Jeffery Schloss, Director, Division of Genome Sciences, National Human Genome Research Institute, NIH will discuss “Developing Technologies for the $1,000 Genome–the Path to Today & Beyond” at GTCbio’s 6th Next Generation Sequencing to be held on May 25-26, 2016 in Boston, MA.

Jeffery A. Schloss is the Director of the Division of Genome Sciences at the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH). The division supports genomic research through investigator-initiated and coordinated programs including NHGRI’s Genome Sequencing Program, ENCODE, Genomics of Gene Regulation, and numerous others. The division is the home for numerous NIH Common Fund programs. Dr. Schloss leads the team that launched and manages the Centers of Excellence in Genomic Science, and initiated a program to foster effective collaborations to validate new sequencing technologies for use in high-throughput laboratories. He implemented and managed the institute’s program to develop technologies with which to sequence entire human genomes at a cost of $1000. He was previously a program director for large-scale genetic mapping, physical mapping, and DNA sequencing projects.

Dr. Schloss represented NHGRI on the NIH Bioengineering Consortium, BECON, established in 1997 to foster support for bioengineering research. Schloss served as the chair of BECON from 2001-2004. He co-organized the BECON 2000 symposium on nanotechnology in biomedicine. He represented the NIH on the National Science and Technology Council’s (NSTC) subcommittee on Nanoscale Science, Engineering and Technology (NSET), planning for the National Nanotechnology Initiative. He also co-chairs the working group for the NIH Nanomedicine Roadmap Initiative. Dr. Schloss has worked with local high school students, teaching about DNA sequencing and the ethical and societal implications of Human Genome Project. Dr. Schloss previously served on the biology faculty at the University of Kentucky. He earned the B.S. degree with honors from Case Western Reserve University, the Ph.D. in Cell Biology from Carnegie-Mellon University, and conducted postdoctoral research at Yale University. His research in cell and molecular biology included the study of non-muscle cell motility and regulation of mRNA expression.

The 6th Next Generation Sequencing Conference will provide attendees with a better understanding of developments in new next generation sequencing technologies alongside clinical applications. There will be a focus on medical sequencing for patient characterization in targeted therapies through vast methods like single cell and RNA sequencing. Implications for how diseases should be treated will be discussed through the examination of data produced from reputable assays.

This conference is also part of the larger Genomics & Big Data Summit, which consists of three additional conferences including this meeting:
6th Next Generation Sequencing
3rd Metabolomics - Advances & Applications in Human Disease Conference
CRISPR & Genome Engineering
Big Data Bioinformatics

For more information, please visit the website: www.gtcbio.com/ngs/agenda

GTCbio
635 W. Foothill Blvd
Monrovia, CA 91016
www.gtcbio.com/
Email: infogtcbio@gtcbio.com
Phone: (626) 256-6405
Fax: (626) 466-4433